fda 503a bulks list bpc-157 category 2 bulk drug substances Major peptide regulatory news this week. The FDA Peptide Reclassification 2026: What

Drug Interactions BPC-157 appears to interact with several medication classes, though most interactions are either neutral or potentially beneficial

A 2026 UK review: 5,000 UK patients, HGF/c-Met motor neuron protection, Engensis (VM202), the May 2026 Longitude Prize on ALS, EXPERTS-ALS, MND-SMART, Read the full review Parkinson's Disease & Neurodegeneration 30 April 2026 Dihexa for Parkinson's Disease: HGF/c-Met Neuroprotection & the 2026 UK Review Can Dihexa help Parkinson's disease

Peptides that promote angiogenesis restore blood flow to damaged nerves, creating the metabolic conditions necessary for regeneration

The practical conclusion: for most people with mild low B12 or dietary gaps, daily methylcobalamin in a quality multivitamin is a better long-term strategy than chasing energy shots

With tirzepatide removed from the shortage list, 503B compounding of standard tirzepatide formulations has been significantly curtailed